section name header

Basics

Basics

Definition

A group of conditions of diverse cause in which extracellular deposition of insoluble fibrillar proteins (amyloid) in various organs and tissues compromises their normal function.

Pathophysiology

  • Patients usually affected by systemic reactive amyloidosis; tissue deposits contain AA, which is a fragment of an acute-phase reactant protein called SAA.
  • Phases of amyloid deposition:
    • Predeposition phase: SAA concentration is high but without amyloid deposits; colchicine administration during this phase may prevent development of the disease.
    • Deposition phase (rapid portion): amyloid deposits increase rapidly; colchicine administration delays but does not prevent tissue deposition of amyloid; DMSO may promote resolution of amyloid deposits and a persistent decrease in SAA concentration.
    • Deposition phase (plateau portion): net deposition of amyloid changes little; neither DMSO nor colchicine is beneficial.
  • Clinical signs in dogs and cats usually are associated with amyloid deposition in the kidneys.
  • Dogs-amyloid deposits usually found in the glomeruli leading to proteinuria and nephrotic syndrome.
  • Cats-amyloid deposits usually found in the medullary interstitium but may occur in glomeruli.
  • Some Chinese shar-pei dogs with familial amyloidosis have medullary amyloidosis without glomerular involvement.
  • Siamese and Oriental shorthair cats with familial amyloidosis have hepatic amyloidosis.
  • A different type amyloid, pancreatic islet amyloid polypeptide, or amylin, deposits in the pancreas of old cats. Amylin is a hormone secreted along with insulin by the pancreatic beta cells. Chronic increased stimulus for secretion of amylin by beta cells (e.g., states of insulin resistance) lead to pancreatic islet cell amyloidosis.

Systems Affected

Renal/Urologic-predilection for renal AA deposition. Liver, spleen, adrenal glands, pancreas, tracheobronchial tree, and gastrointestinal tract also may be affected.

Genetic

(See “Breed Predilections.”) No genetic involvement is clearly established; familial amyloidosis occurs in Chinese shar-pei, English foxhound, and beagle dogs, and in Abyssinian, Oriental shorthair, and Siamese cats.

Incidence/Prevalence

Uncommon, occurs mostly in dogs; rare in cats, except Abyssinians.

Signalment

Species

Dog and cat

Breed Predilections

  • Dog-Chinese shar-pei, beagle, collie, pointer, English foxhound, and walker hound; German shepherd dog and mixed breeds are at lower risk.
  • Cat-Abyssinian, Oriental shorthair, and Siamese.

Mean Age and Range

  • Cats-mean age at diagnosis 7 years; range 1–17 years.
  • Dogs-mean age at diagnosis is 9 years; range 1–15 years. Chinese shar-Pei dogs-median age at diagnosis is 5 years; range 3.6–17 years.
  • Prevalence increases with age.
  • Abyssinian cats-range <1–17 years.
  • Chinese shar-pei dogs-usually <6 years of age when signs of renal failure develop.
  • Siamese cats with familial amyloidosis of the liver and thyroid gland usually develop signs of liver disease when 1–4 years old.

Predominant Sex

Dogs and Abyssinian cats-females at a slightly higher risk (<2:1). Female-to-male ratio is higher in Chinese shar-pei dogs (∼ 2.5:1).

Signs

General Comments

  • Depend on the organs affected, the amount of amyloid, and the reaction of the affected organs to amyloid deposits.
  • Usually caused by kidney involvement; occasionally, hepatic involvement may cause signs in Chinese shar-pei dogs and Oriental shorthair and Siamese cats.

Historical Findings

  • No clear history of a predisposing disorder in most (∼75%) cases.
  • Anorexia, lethargy, polyuria and polydipsia, weight loss, vomiting.
  • Ascites and peripheral edema in animals with nephrotic syndrome.
  • Chinese shar-pei dogs may have a history of previous episodic joint swelling and high fever that resolves spontaneously within a few days.
  • Beagle dogs with juvenile polyarteritis may have a history of fever and neck pain that persist for 3–7 days.
  • Oriental shorthair and Siamese cats may present with spontaneous hepatic hemorrhage leading to acute collapse and hemoabdomen.

Physical Examination Findings

  • Related to renal failure-oral ulceration, emaciation, vomiting, and dehydration; kidneys usually small, firm, and irregular in affected cats; they may be small, normal-sized, or slightly enlarged in affected dogs.
  • Signs of nephrotic syndrome (e.g., ascites, subcutaneous edema).
  • Related to the primary inflammatory or neoplastic disease process.
  • Thromboembolic phenomena-may occur in up to 40% of affected dogs; signs vary with the location of the thrombus; patients may develop pulmonary thromboembolism (e.g., dyspnea) or iliac or femoral artery thromboembolism (e.g., caudal paresis).
  • Chinese shar-pei dogs and Oriental shorthair and Siamese cats may have signs of hepatic disease (e.g., jaundice, cachexia, and spontaneous hepatic rupture with intraperitoneal bleeding).

Causes

  • Neoplasia and chronic infectious and non-infectious inflammatory conditions can be found in 30–50% of dogs with reactive amyloidosis.
  • Chronic inflammation-systemic mycoses (e.g., blastomycosis, coccidioidomycosis), chronic bacterial infections (e.g., osteomyelitis, bronchopneumonia, pleuritis, steatitis, pyometra, pyelonephritis, chronic suppurative dermatitis, chronic suppurative arthritis, chronic peritonitis, nocardiosis, chronic stomatitis), parasitic infections (e.g., dirofilariasis, leishmaniasis, hepatozoonosis), and immune-mediated diseases (e.g., systemic lupus erythematosus). Amyloid deposits can be found in up to 35% of FIV-positive cats.
  • Neoplasia (e.g., lymphoma, plasmacytoma, multiple myeloma, mammary tumors, testicular tumors).
  • Familial (e.g., Chinese shar-pei, English foxhound, and beagle dogs; Abyssinian, Siamese, and Oriental shorthair cats).
  • Others-cyclic hematopoiesis in gray collies; juvenile polyarteritis in beagles.

Diagnosis

Diagnosis

Differential Diagnosis

  • Dogs-GN; proteinuria tends to be more severe in dogs with glomerular amyloidosis than those with GN but there is great overlap.
  • Cats and Chinese shar-pei dogs with medullary amyloidosis-consider other causes of medullary renal disease (e.g., pyelonephritis, chronic interstitial disease).

CBC/Biochemistry/Urinalysis

  • Nonregenerative anemia is found in some dogs and cats with amyloid-induced renal failure.
  • Dogs-may see hypercholesterolemia (>85%), azotemia (>70%), hypoalbuminemia (70%), hyperphosphatemia (>60%), hypocalcemia (50%), and metabolic acidosis.
  • Hypercholesterolemia-common finding in cats with renal disorders (>70% of cats with renal disease in one study) but does not reliably predict glomerular disease.
  • Hypoproteinemia-more common than hyperproteinemia (24vs. 8.5%) in dogs with amyloidosis; hyperglobulinemia common in cats.
  • Proteinuria-with an inactive sediment common in dogs; mild or absent in animals with medullary amyloidosis without glomerular involvement (most mixed-breed cats, at least 25% of Abyssinian cats, and at least 33% of Chinese shar-pei dogs). In a retrospective study with 91cases of renal amyloidosis in dogs, hypoalbuminemia was more common in non-Chinese shar-pei dogs (100%) versus shar-pei dogs (65%).
  • Isosthenuria, and hyaline, granular, and waxy casts in some patients.

Other Laboratory Tests

Proteinuria-urinary protein:creatinine ratio to estimate severity.

Imaging

Abdominal Radiographic Findings

  • Kidneys usually small in affected cats.
  • Kidneys small, normal-sized, or large in affected dogs.

Abdominal Ultrasonographic Findings

Kidneys usually hyperechoic and small in affected cats; may be small, normal-sized, or large in affected dogs.

Diagnostic Procedures

Renal biopsy needed to differentiate amyloidosis from GN. In dogs other than Chinese shar-pei, amyloidosis is primarily a glomerular disease; diagnose by renal cortical biopsy. In most domestic cats, some Abyssinian cats, and some Chinese shar-pei dogs, medullary amyloidosis can occur without glomerular involvement; diagnose by renal medullary biopsy.

Pathologic Findings

  • Small kidneys in cats; small, normal, or large kidneys in dogs.
  • Amyloid deposits appear homogeneous and eosinophilic when stained by hematoxylin and eosin and viewed by conventional light microscopy. They demonstrate green birefringence after Congo red staining when viewed under polarized light. Evaluation of Congo red-stained sections before and after permanganate oxidation permits presumptive diagnosis of AA amyloidosis (vs. other types) because AA amyloidosis loses its Congo red affinity after permanganate oxidation.
  • The liver is very friable and usually contains extensive amyloid deposits in cats presented with acute hepatic hemorrhage.

Treatment

Treatment

Appropriate Health Care

  • Hospitalize patients with chronic renal failure and dehydration for initial medical management.
  • Can manage stable patients and those with asymptomatic proteinuria as outpatients.

Diet

  • Patients with chronic renal failure-restrict phosphorus and moderately restrict protein.
  • Patients with hypertension-restrict sodium.

Client Education

  • Discuss progression of the disease.
  • Discuss familial predisposition in susceptible breeds.

Medications

Medications

Drug(s) Of Choice

  • Identify underlying inflammatory and neoplastic processes and treat if possible.
  • Manage renal failure according to the principles of conservative medical treatment (see Renal Failure, Acute, and Renal Failure, Chronic).
  • Normalize blood pressure in patients with hypertension (see Hypertension, Systemic).
  • Patients with thromboembolic syndrome and nephrotic syndrome caused by glomerular amyloidosis usually have a low plasma concentration of antithrombin; thus heparin is relatively ineffective. Aspirin (0.5 mg/kg PO q12h) has been suggested for dogs with glomerular disease; this low dosage is as effective in preventing platelet aggregation as is 10 mg/kg PO q24h.
  • DMSO-may help patients by solubilizing amyloid fibrils, reducing serum concentration of SAA, and reducing interstitial inflammation and fibrosis in the affected kidneys; may cause lens opacification in dogs. Perivascular inflammation and local thrombosis may occur if undiluted DMSO is administered intravenously. Subcutaneous administration of undiluted DMSO may be painful. The authors have used 90% DMSO diluted 1:4with sterile water subcutaneously at a dosage of 90 mg/kg 3times per week in dogs. Whether or not DMSO treatment benefits renal amyloidosis in dogs remains controversial.
  • Methylsulfonylmethane is an active metabolite of DMSO that can be given orally and lacks the smell of DMSO. It has been used empirically in dogs with amyloidosis, but there is no evidence that it benefits dogs with renal amyloidosis.
  • Colchicine-impairs release of SAA from hepatocytes; prevents development of amyloidosis in humans with familial Mediterranean fever (a familial amyloidosis) and stabilizes renal function in patients with nephrotic syndrome but without overt renal failure; no evidence of benefit once the patient develops renal failure; may cause vomiting, diarrhea, and idiosyncratic neutropenia in dogs. Colchicine (0.01–0.04 mg/kg PO q24h) is used particularly in shar-pei dogs with episodic fever or polyarthritis before development of renal failure.

Precautions

  • Dosage of drugs excreted by the kidneys may need adjustment in patients with renal failure.
  • Use nonsteroidal anti-inflammatory drugs cautiously in patients with medullary amyloidosis; they can decrease renal blood flow in dehydrated patients.

Follow-Up

Follow-Up

Patient Monitoring

  • Appetite and activity level daily by the owner; body weight weekly.
  • Serum albumin, creatinine, and BUN concentrations every 2–6months in stable patients.
  • Can assess degree of proteinuria serially by urine protein:creatinine ratios.

Prevention/Avoidance

Do not breed affected animals.

Possible Complications

  • Renal failure
  • Nephrotic syndrome
  • Systemic hypertension
  • Hepatic rupture causing intraperitoneal hemorrhage
  • Thromboembolic disease

Expected Course and Prognosis

Disease is progressive and usually advanced at the time of diagnosis. Prognosis improves if an underlying immune, inflammatory, or neoplastic disease is detected and successfully treated. Survival for dogs with glomerular amyloidosis varied from 3to 20months in 1study; some dogs may occasionally live longer. Cats with renal failure because of amyloidosis usually survive <1 year. Mildly affected cats may not develop renal failure and have an almost normal life expectancy.

Miscellaneous

Miscellaneous

Associated Conditions

  • Urinary tract infection
  • Polyarthritis in Chinese shar-pei
  • Polyarteritis in beagle

Abbreviations

  • AA = amyloid A protein
  • DMSO = dimethylsulfoxide
  • GN = glomerula nephritis
  • SAA = serum amyloid A protein

Suggested Reading

Bartges J, Wall J. Amyloidosis. In Bartges J, Polzin DJ. Nephrology and Urology of Small Animals, Oxford: Wiley-Blackwell, 2011, pp. 547554.

Segev G, Cowgill , LD, Jessen , S et al. Renal amyloidosis in dogs: a retrospective study of 91cases with comparison of the between Shar-pei and non-Shar-pei dogs. J Vet Intern Med 2012, 26:259268.

Authors Helio S. Autran de Morais and Stephen P. DiBartola

Consulting Editor Carl A. Osborne

Client Education Handout Available Online